Abstract
Although stroke is very often the cause of death worldwide, the burden of ischemic and hemorrhagic stroke varies between regions and over time regarding differences in prognosis, prevalence of risk factors, and treatment strategies. Excitotoxicity, oxidative stress, dysfunction of the blood-brain barrier, neuroinflammation, and lysosomal membrane permeabilization, sequentially lead to the progressive death of neurons. In this process, protein kinases-related checkpoints tightly regulate N-methyl-D-aspartate (NMDA) receptor signaling pathways. One of the major hallmarks of cerebral ischemia is excitotoxicity, characterized by overactivation of glutamate receptors leading to intracellular Ca2+ overload and ultimately neuronal death. Thus, reduced expression of postsynaptic density-95 protein and increased protein S-nitrosylation in neurons is responsible for neuronal vulnerability in cerebral ischemia. In this chapter death-associated protein kinases, cyclin-dependent kinase 5, endoplasmic reticulum stress-induced protein kinases, hyperhomocysteinemia-related NMDA receptor overactivation, ephrin-B-dependent amplification of NMDA-evoked neuronal excitotoxicity and lysosomocentric hypothesis have been discussed.
Consequently, ample evidences have demonstrated that enhancing extrasynaptic NMDA receptor activity triggers cell death after stroke. In this context, considering the dual roles of NMDA receptors in both promoting neuronal survival and mediating neuronal damage, selective augmentation of NR2A-containing NMDA receptor activation in the presence of NR2B antagonist may constitute a promising therapy for stroke.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aarts MM, Arundine M, Tymianski M. Novel concepts in excitotoxic neurodegeneration after stroke. Expert Rev Mol Med. 2003;5:1–22. https://doi.org/10.1017/S1462399403007087.
Abramov AY, Duchen MR. Mechanisms underlying the loss of mitochondrial membrane potential in glutamate excitotoxicity. Biochim Biophys Acta. 2008;1777:953–64. https://doi.org/10.1016/j.bbabio.2008.04.017.
Abramov AY, Scorziello A, Duchen MR. Three distinct mechanisms generate oxygen free radicals in neurons and contribute to cell death during anoxia and reoxygenation. J Neurosci. 2007;27:1129–38. https://doi.org/10.1523/JNEUROSCI.4468-06.2007.
Adibhatla RM, Hatcher JF, Dempsey RJ. Phospholipase A2, hydroxyl radicals, and lipid peroxidation in transient cerebral ischemia. Antioxid Redox Signal. 2003;5:647–54. https://doi.org/10.1089/152308603770310329.
Aleyasin H, Rousseaux MWC, Phillips M, Kim RH, Bland RJ, Callaghan S, Slack RS, During MJ, Mak TW, Park DS. The Parkinson’s disease gene DJ-1 is also a key regulator of stroke-induced damage. Proc Natl Acad Sci U S A. 2007;104:18748–53. https://doi.org/10.1073/pnas.0709379104.
Anniwaer J, Liu M-Z, Xue K-D, Maimaiti A, Xiamixiding A. Homocysteine might increase the risk of recurrence in patients presenting with primary cerebral infarction. Int J Neurosci. 2019;129:654–9. https://doi.org/10.1080/00207454.2018.1517762.
Anrather J, Iadecola C. Inflammation and stroke: an overview. Neurotherapeutics. 2016;13:661–70. https://doi.org/10.1007/s13311-016-0483-x.
Arundine M, Tymianski M. Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity. Cell Calcium. 2003;34:325–37. https://doi.org/10.1016/s0143-4160(03)00141-6.
Bach A, Clausen BH, Møller M, Vestergaard B, Chi CN, Round A, Sørensen PL, Nissen KB, Kastrup JS, Gajhede M, Jemth P, Kristensen AS, Lundström P, Lambertsen KL, Strømgaard K. A high-affinity, dimeric inhibitor of PSD-95 bivalently interacts with PDZ1-2 and protects against ischemic brain damage. Proc Natl Acad Sci U S A. 2012;109:3317–22. https://doi.org/10.1073/pnas.1113761109.
Bach A, Clausen BH, Kristensen LK, Andersen MG, Ellman DG, Hansen PBL, Hasseldam H, Heitz M, Özcelik D, Tuck EJ, Kopanitsa MV, Grant SGN, Lykke-Hartmann K, Johansen FF, Lambertsen KL, Strømgaard K. Selectivity, efficacy and toxicity studies of UCCB01-144, a dimeric neuroprotective PSD-95 inhibitor. Neuropharmacology. 2019;150:100–11. https://doi.org/10.1016/j.neuropharm.2019.02.035.
Bading H. Therapeutic targeting of the pathological triad of extrasynaptic NMDA receptor signaling in neurodegenerations. J Exp Med. 2017;214:569–78. https://doi.org/10.1084/jem.20161673.
Bao X-M, Wu C-F, Lu G-P. Atorvastatin inhibits homocysteine-induced oxidative stress and apoptosis in endothelial progenitor cells involving Nox4 and p38MAPK. Atherosclerosis. 2010;210:114–21. https://doi.org/10.1016/j.atherosclerosis.2009.11.032.
Bayraktutan U. Endothelial progenitor cells: potential novel therapeutics for ischaemic stroke. Pharmacol Res. 2019;144:181–91. https://doi.org/10.1016/j.phrs.2019.04.017.
Benveniste H, Jørgensen MB, Diemer NH, Hansen AJ. Calcium accumulation by glutamate receptor activation is involved in hippocampal cell damage after ischemia. Acta Neurol Scand. 1988;78:529–36. https://doi.org/10.1111/j.1600-0404.1988.tb03697.x.
Besshoh S, Bawa D, Teves L, Wallace MC, Gurd JW. Increased phosphorylation and redistribution of NMDA receptors between synaptic lipid rafts and post-synaptic densities following transient global ischemia in the rat brain. J Neurochem. 2005;93:186–94. https://doi.org/10.1111/j.1471-4159.2004.03009.x.
Bhalodia YS, Sheth NR, Vaghasiya JD, Jivani NP. Homocysteine-dependent endothelial dysfunction induced by renal ischemia/reperfusion injury. J Nephrol. 2011;24:631–5. https://doi.org/10.5301/JN.2011.6245.
Bialik S, Kimchi A. The DAP-kinase interactome. Apoptosis. 2014;19:316–28. https://doi.org/10.1007/s10495-013-0926-3.
Bosutti A, Qi J, Pennucci R, Bolton D, Matou S, Ali K, Tsai L-H, Krupinski J, Petcu EB, Montaner J, Al Baradie R, Caccuri F, Caruso A, Alessandri G, Kumar S, Rodriguez C, Martinez-Gonzalez J, Slevin M. Targeting p35/Cdk5 signalling via CIP-peptide promotes angiogenesis in hypoxia. PLoS One. 2013;8:e75538. https://doi.org/10.1371/journal.pone.0075538.
Boya P, Kroemer G. Lysosomal membrane permeabilization in cell death. Oncogene. 2008;27:6434–51. https://doi.org/10.1038/onc.2008.310.
Brassai A, Suvanjeiev R-G, Bán E-G, Lakatos M. Role of synaptic and nonsynaptic glutamate receptors in ischaemia induced neurotoxicity. Brain Res Bull. 2015;112:1–6. https://doi.org/10.1016/j.brainresbull.2014.12.007.
Brenman JE, Chao DS, Gee SH, McGee AW, Craven SE, Santillano DR, Wu Z, Huang F, Xia H, Peters MF, Froehner SC, Bredt DS. Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha1-syntrophin mediated by PDZ domains. Cell. 1996;84:757–67. https://doi.org/10.1016/s0092-8674(00)81053-3.
Brennan AM, Suh SW, Won SJ, Narasimhan P, Kauppinen TM, Lee H, Edling Y, Chan PH, Swanson RA. NADPH oxidase is the primary source of superoxide induced by NMDA receptor activation. Nat Neurosci. 2009;12:857–63. https://doi.org/10.1038/nn.2334.
Brennan-Minnella AM, Shen Y, El-Benna J, Swanson RA. Phosphoinositide 3-kinase couples NMDA receptors to superoxide release in excitotoxic neuronal death. Cell Death Dis. 2013;4:e580. https://doi.org/10.1038/cddis.2013.111.
Centeno C, Repici M, Chatton J-Y, Riederer BM, Bonny C, Nicod P, Price M, Clarke PGH, Papa S, Franzoso G, Borsello T. Role of the JNK pathway in NMDA-mediated excitotoxicity of cortical neurons. Cell Death Differ. 2007;14:240–53. https://doi.org/10.1038/sj.cdd.4401988.
Chang N, Li L, Hu R, Shan Y, Liu B, Li L, Wang H, Feng H, Wang D, Cheung C, Liao M, Wan Q. Differential regulation of NMDA receptor function by DJ-1 and PINK1. Aging Cell. 2010;9:837–50. https://doi.org/10.1111/j.1474-9726.2010.00615.x.
Chen H, Yoshioka H, Kim GS, Jung JE, Okami N, Sakata H, Maier CM, Narasimhan P, Goeders CE, Chan PH. Oxidative stress in ischemic brain damage: mechanisms of cell death and potential molecular targets for neuroprotection. Antioxid Redox Signal. 2011;14:1505–17. https://doi.org/10.1089/ars.2010.3576.
Cheng Y-L, Choi Y, Seow WL, Manzanero S, Sobey CG, Jo D-G, Arumugam TV. Evidence that neuronal Notch-1 promotes JNK/c-Jun activation and cell death following ischemic stress. Brain Res. 2014;1586:193–202. https://doi.org/10.1016/j.brainres.2014.08.054.
Choi YB, Tenneti L, Le DA, Ortiz J, Bai G, Chen HS, Lipton SA. Molecular basis of NMDA receptor-coupled ion channel modulation by S-nitrosylation. Nat Neurosci. 2000;3:15–21. https://doi.org/10.1038/71090.
Choi DW, Na W, Kabir MH, Yi E, Kwon S, Yeom J, Ahn J-W, Choi H-H, Lee Y, Seo KW, Shin MK, Park S-H, Yoo HY, Isono K-I, Koseki H, Kim S-T, Lee C, Kwon YK, Choi CY. WIP1, a homeostatic regulator of the DNA damage response, is targeted by HIPK2 for phosphorylation and degradation. Mol Cell. 2013;51:374–85. https://doi.org/10.1016/j.molcel.2013.06.010.
Copani A, Uberti D, Sortino MA, Bruno V, Nicoletti F, Memo M. Activation of cell-cycle-associated proteins in neuronal death: a mandatory or dispensable path? Trends Neurosci. 2001;24:25–31. https://doi.org/10.1016/s0166-2236(00)01663-5.
da Cunha MJ, da Cunha AA, Ferreira AGK, Machado FR, Schmitz F, Lima DD, Delwing D, Mussulini BHM, Wofchuk S, Netto CA, Wyse ATS. Physical exercise reverses glutamate uptake and oxidative stress effects of chronic homocysteine administration in the rat. Int J Dev Neurosci. 2012;30:69–74. https://doi.org/10.1016/j.ijdevneu.2012.01.001.
Dalva MB, Takasu MA, Lin MZ, Shamah SM, Hu L, Gale NW, Greenberg ME. EphB receptors interact with NMDA receptors and regulate excitatory synapse formation. Cell. 2000;103:945–56. https://doi.org/10.1016/s0092-8674(00)00197-5.
DeGracia DJ, Montie HL. Cerebral ischemia and the unfolded protein response. J Neurochem. 2004;91:1–8. https://doi.org/10.1111/j.1471-4159.2004.02703.x.
Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 1999;22:391–7. https://doi.org/10.1016/s0166-2236(99)01401-0.
Eisenberg-Lerner A, Kimchi A. DAP kinase regulates JNK signaling by binding and activating protein kinase D under oxidative stress. Cell Death Differ. 2007;14:1908–15. https://doi.org/10.1038/sj.cdd.4402212.
Ernst A-S, Böhler L-I, Hagenston AM, Hoffmann A, Heiland S, Sticht C, Bendszus M, Hecker M, Bading H, Marti HH, Korff T, Kunze R. EphB2-dependent signaling promotes neuronal excitotoxicity and inflammation in the acute phase of ischemic stroke. Acta Neuropathol Commun. 2019;7:15. https://doi.org/10.1186/s40478-019-0669-7.
Fann DY-W, Lee S-Y, Manzanero S, Chunduri P, Sobey CG, Arumugam TV. Pathogenesis of acute stroke and the role of inflammasomes. Ageing Res Rev. 2013;12:941–66. https://doi.org/10.1016/j.arr.2013.09.004.
Fann DY-W, Lim Y-A, Cheng Y-L, Lok K-Z, Chunduri P, Baik S-H, Drummond GR, Dheen ST, Sobey CG, Jo D-G, Chen CL-H, Arumugam TV. Evidence that NF-κB and MAPK signaling promotes NLRP inflammasome activation in neurons following ischemic stroke. Mol Neurobiol. 2018;55:1082–96. https://doi.org/10.1007/s12035-017-0394-9.
Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA, Moran AE, Sacco RL, Anderson L, Truelsen T, O’Donnell M, Venketasubramanian N, Barker-Collo S, Lawes CMM, Wang W, Shinohara Y, Witt E, Ezzati M, Naghavi M, Murray C, Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) and the GBD Stroke Experts Group. Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet. 2014;383:245–54. https://doi.org/10.1016/s0140-6736(13)61953-4.
Fiorentini M, Bach A, Strømgaard K, Kastrup JS, Gajhede M. Interaction partners of PSD-93 studied by X-ray crystallography and fluorescence polarization spectroscopy. Acta Crystallogr D Biol Crystallogr. 2013;69:587–94. https://doi.org/10.1107/S0907444912051839.
Gao J, Duan B, Wang D-G, Deng X-H, Zhang G-Y, Xu L, Xu T-L. Coupling between NMDA receptor and acid-sensing ion channel contributes to ischemic neuronal death. Neuron. 2005;48:635–46. https://doi.org/10.1016/j.neuron.2005.10.011.
Gardoni F, Bellone C, Viviani B, Marinovich M, Meli E, Pellegrini-Giampietro DE, Cattabeni F, Di Luca M. Lack of PSD-95 drives hippocampal neuronal cell death through activation of an alpha CaMKII transduction pathway. Eur J Neurosci. 2002;16:777–86. https://doi.org/10.1046/j.1460-9568.2002.02141.x.
Gardoni F, Polli F, Cattabeni F, Di Luca M. Calcium-calmodulin-dependent protein kinase II phosphorylation modulates PSD-95 binding to NMDA receptors. Eur J Neurosci. 2006;24:2694–704. https://doi.org/10.1111/j.1460-9568.2006.05140.x.
George PM, Steinberg GK. Novel stroke therapeutics: unraveling stroke pathophysiology and its impact on clinical treatments. Neuron. 2015;87:297–309. https://doi.org/10.1016/j.neuron.2015.05.041.
Gisselsson L, Toresson H, Ruscher K, Wieloch T. Rho kinase inhibition protects CA1 cells in organotypic hippocampal slices during in vitro ischemia. Brain Res. 2010;1316:92–100. https://doi.org/10.1016/j.brainres.2009.11.087.
Gomes JR, Costa JT, Melo CV, Felizzi F, Monteiro P, Pinto MJ, Inácio AR, Wieloch T, Almeida RD, Grãos M, Duarte CB. Excitotoxicity downregulates TrkB.FL signaling and upregulates the neuroprotective truncated TrkB receptors in cultured hippocampal and striatal neurons. J Neurosci. 2012;32:4610–22. https://doi.org/10.1523/JNEUROSCI.0374-12.2012.
Hanamura K, Washburn HR, Sheffler-Collins SI, Xia NL, Henderson N, Tillu DV, Hassler S, Spellman DS, Zhang G, Neubert TA, Price TJ, Dalva MB. Extracellular phosphorylation of a receptor tyrosine kinase controls synaptic localization of NMDA receptors and regulates pathological pain. PLoS Biol. 2017;15:e2002457. https://doi.org/10.1371/journal.pbio.2002457.
Hao L, Wei X, Guo P, Zhang G, Qi S. Neuroprotective effects of inhibiting Fyn S-nitrosylation on cerebral ischemia/reperfusion-induced damage to CA1 hippocampal neurons. Int J Mol Sci. 2016;17:1100. https://doi.org/10.3390/ijms17071100.
Hardingham GE. Coupling of the NMDA receptor to neuroprotective and neurodestructive events. Biochem Soc Trans. 2009;37:1147–60. https://doi.org/10.1042/BST0371147.
Hardingham GE, Fukunaga Y, Bading H. Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat Neurosci. 2002;5:405–14. https://doi.org/10.1038/nn835.
Henning EC, Warach S, Spatz M. Hypertension-induced vascular remodeling contributes to reduced cerebral perfusion and the development of spontaneous stroke in aged SHRSP rats. J Cereb Blood Flow Metab. 2010;30:827–36. https://doi.org/10.1038/jcbfm.2009.246.
Hetman M, Kharebava G. Survival signaling pathways activated by NMDA receptors. Curr Top Med Chem. 2006;6:787–99. https://doi.org/10.2174/156802606777057553.
Higuchi M, Tomioka M, Takano J, Shirotani K, Iwata N, Masumoto H, Maki M, Itohara S, Saido TC. Distinct mechanistic roles of calpain and caspase activation in neurodegeneration as revealed in mice overexpressing their specific inhibitors. J Biol Chem. 2005;280:15229–37. https://doi.org/10.1074/jbc.M500939200.
Hofmann TG, Stollberg N, Schmitz ML, Will H. HIPK2 regulates transforming growth factor-beta-induced c-Jun NH(2)-terminal kinase activation and apoptosis in human hepatoma cells. Cancer Res. 2003;63:8271–7.
Hossain MI, Kamaruddin MA, Cheng H-C. Aberrant regulation and function of Src family tyrosine kinases: their potential contributions to glutamate-induced neurotoxicity. Clin Exp Pharmacol Physiol. 2012;39:684–91. https://doi.org/10.1111/j.1440-1681.2011.05621.x.
Hou X-Y, Zhang G-Y, Yan J-Z, Chen M, Liu Y. Activation of NMDA receptors and L-type voltage-gated calcium channels mediates enhanced formation of Fyn-PSD95-NR2A complex after transient brain ischemia. Brain Res. 2002;955:123–32. https://doi.org/10.1016/s0006-8993(02)03376-0.
Hou X-Y, Zhang G-Y, Wang D-G, Guan Q-H, Yan J-Z. Suppression of postsynaptic density protein 95 by antisense oligonucleotides diminishes postischemic pyramidal cell death in rat hippocampal CA1 subfield. Neurosci Lett. 2005;385:230–3. https://doi.org/10.1016/j.neulet.2005.05.054.
Hou X-Y, Liu Y, Zhang G-Y. PP2, a potent inhibitor of Src family kinases, protects against hippocampal CA1 pyramidal cell death after transient global brain ischemia. Neurosci Lett. 2007;420:235–9. https://doi.org/10.1016/j.neulet.2007.03.048.
Huang B, Chen P, Huang L, Li S, Zhu R, Sheng T, Yu W, Chen Z, Wang T. Geniposide attenuates post-ischaemic neurovascular damage via GluN2A/AKT/ERK-dependent mechanism. Cell Physiol Biochem. 2017;43:705–16. https://doi.org/10.1159/000480657.
Hughes JP, Staton PC, Wilkinson MG, Strijbos PJLM, Skaper SD, Arthur JSC, Reith AD. Mitogen and stress response kinase-1 (MSK1) mediates excitotoxic induced death of hippocampal neurones. J Neurochem. 2003;86:25–32. https://doi.org/10.1046/j.1471-4159.2003.01830.x.
Iriyama T, Kamei Y, Kozuma S, Taketani Y. Bax-inhibiting peptide protects glutamate-induced cerebellar granule cell death by blocking Bax translocation. Neurosci Lett. 2009;451:11–5. https://doi.org/10.1016/j.neulet.2008.12.021.
Irving EA, Bamford M. Role of mitogen- and stress-activated kinases in ischemic injury. J Cereb Blood Flow Metab. 2002;22:631–47. https://doi.org/10.1097/00004647-200206000-00001.
Jara JH, Singh BB, Floden AM, Combs CK. Tumor necrosis factor alpha stimulates NMDA receptor activity in mouse cortical neurons resulting in ERK-dependent death. J Neurochem. 2007;100:1407–20. https://doi.org/10.1111/j.1471-4159.2006.04330.x.
Jayaraj RL, Azimullah S, Beiram R, Jalal FY, Rosenberg GA. Neuroinflammation: friend and foe for ischemic stroke. J Neuroinflammation. 2019;16:142. https://doi.org/10.1186/s12974-019-1516-2.
Ji Y, Song B, Xu Y, Fang H, Wu J, Sun S, Zhao L, Shi C, Gao Y, Tao Y, Li Y. Prognostic significance of homocysteine levels in acute ischemic stroke: a prospective cohort study. Curr Neurovasc Res. 2015;12:334–40. https://doi.org/10.2174/1567202612666150807112205.
Ji Y-B, Zhuang P-P, Ji Z, Wu Y-M, Gu Y, Gao X-Y, Pan S-Y, Hu Y-F. TFP5 peptide, derived from CDK5-activating cofactor p35, provides neuroprotection in early-stage of adult ischemic stroke. Sci Rep. 2017;7:40013. https://doi.org/10.1038/srep40013.
Jiang Q, Gu Z, Zhang G, Jing G. N-methyl-D-aspartate receptor activation results in regulation of extracellular signal-regulated kinases by protein kinases and phosphatases in glutamate-induced neuronal apototic-like death. Brain Res. 2000;887:285–92. https://doi.org/10.1016/s0006-8993(00)03003-1.
Jiang S, Li T, Ji T, Yi W, Yang Z, Wang S, Yang Y, Gu C. AMPK: potential therapeutic target for ischemic stroke. Theranostics. 2018;8:4535–51. https://doi.org/10.7150/thno.25674.
Jin R, Yang G, Li G. Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J Leukoc Biol. 2010;87:779–89. https://doi.org/10.1189/jlb.1109766.
Jindal A, Rajagopal S, Winter L, Miller JW, Jacobsen DW, Brigman J, Allan AM, Paul S, Poddar R. Hyperhomocysteinemia leads to exacerbation of ischemic brain damage: role of GluN2A NMDA receptors. Neurobiol Dis. 2019;127:287–302. https://doi.org/10.1016/j.nbd.2019.03.012.
Johansson A-C, Appelqvist H, Nilsson C, Kågedal K, Roberg K, Ollinger K. Regulation of apoptosis-associated lysosomal membrane permeabilization. Apoptosis. 2010;15:527–40. https://doi.org/10.1007/s10495-009-0452-5.
Kågedal K, Zhao M, Svensson I, Brunk UT. Sphingosine-induced apoptosis is dependent on lysosomal proteases. Biochem J. 2001;359:335–43. https://doi.org/10.1042/0264-6021:3590335.
Kim MJ, Dunah AW, Wang YT, Sheng M. Differential roles of NR2A- and NR2B-containing NMDA receptors in Ras-ERK signaling and AMPA receptor trafficking. Neuron. 2005;46:745–60. https://doi.org/10.1016/j.neuron.2005.04.031.
Krishnamurthi RV, Feigin VL, Forouzanfar MH, Mensah GA, Connor M, Bennett DA, Moran AE, Sacco RL, Anderson LM, Truelsen T, O’Donnell M, Venketasubramanian N, Barker-Collo S, Lawes CMM, Wang W, Shinohara Y, Witt E, Ezzati M, Naghavi M, Murray C, Global Burden of Diseases, Injuries, Risk Factors Study 2010 (GBD 2010), GBD Stroke Experts Group. Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet Glob Health. 2013;1:e259–81. https://doi.org/10.1016/S2214-109X(13)70089-5.
Kruman II, Culmsee C, Chan SL, Kruman Y, Guo Z, Penix L, Mattson MP. Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J Neurosci. 2000;20:6920–6.
Kruman II, Kumaravel TS, Lohani A, Pedersen WA, Cutler RG, Kruman Y, Haughey N, Lee J, Evans M, Mattson MP. Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer’s disease. J Neurosci. 2002;22:1752–62.
Kumar R, Azam S, Sullivan JM, Owen C, Cavener DR, Zhang P, Ron D, Harding HP, Chen JJ, Han A, White BC, Krause GS, DeGracia DJ. Brain ischemia and reperfusion activates the eukaryotic initiation factor 2alpha kinase, PERK. J Neurochem. 2001;77:1418–21. https://doi.org/10.1046/j.1471-4159.2001.00387.x.
Kuwana T, Mackey MR, Perkins G, Ellisman MH, Latterich M, Schneiter R, Green DR, Newmeyer DD. Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell. 2002;111:331–42. https://doi.org/10.1016/s0092-8674(02)01036-x.
Lai TW, Zhang S, Wang YT. Excitotoxicity and stroke: identifying novel targets for neuroprotection. Prog Neurobiol. 2014;115:157–88. https://doi.org/10.1016/j.pneurobio.2013.11.006.
Lazarewicz JW, Salinska E, Wroblewski JT. NMDA receptor-mediated arachidonic acid release in neurons: role in signal transduction and pathological aspects. Adv Exp Med Biol. 1992;318:73–89. https://doi.org/10.1007/978-1-4615-3426-6_7.
Lee B, Butcher GQ, Hoyt KR, Impey S, Obrietan K. Activity-dependent neuroprotection and cAMP response element-binding protein (CREB): kinase coupling, stimulus intensity, and temporal regulation of CREB phosphorylation at serine 133. J Neurosci. 2005;25:1137–48. https://doi.org/10.1523/JNEUROSCI.4288-04.2005.
Lee S, Shang Y, Redmond SA, Urisman A, Tang AA, Li KH, Burlingame AL, Pak RA, Jovičić A, Gitler AD, Wang J, Gray NS, Seeley WW, Siddique T, Bigio EH, Lee VM-Y, Trojanowski JQ, Chan JR, Huang EJ. Activation of HIPK2 promotes ER stress-mediated neurodegeneration in amyotrophic lateral sclerosis. Neuron. 2016;91:41–55. https://doi.org/10.1016/j.neuron.2016.05.021.
Lehotsky J, Petras M, Kovalska M, Tothova B, Drgova A, Kaplan P. Mechanisms involved in the ischemic tolerance in brain: effect of the homocysteine. Cell Mol Neurobiol. 2015;35:7–15. https://doi.org/10.1007/s10571-014-0112-3.
Li JH, Wang YH, Wolfe BB, Krueger KE, Corsi L, Stocca G, Vicini S. Developmental changes in localization of NMDA receptor subunits in primary cultures of cortical neurons. Eur J Neurosci. 1998;10:1704–15. https://doi.org/10.1046/j.1460-9568.1998.00169.x.
Li B, Chen N, Luo T, Otsu Y, Murphy TH, Raymond LA. Differential regulation of synaptic and extra-synaptic NMDA receptors. Nat Neurosci. 2002;5:833–4. https://doi.org/10.1038/nn912.
Li J, Ma X, Yu W, Lou Z, Mu D, Wang Y, Shen B, Qi S. Reperfusion promotes mitochondrial dysfunction following focal cerebral ischemia in rats. PLoS One. 2012;7:e46498. https://doi.org/10.1371/journal.pone.0046498.
Li D, Luo L, Xu M, Wu J, Chen L, Li J, Liu Z, Lu G, Wang Y, Qiao L. AMPK activates FOXO3a and promotes neuronal apoptosis in the developing rat brain during the early phase after hypoxia-ischemia. Brain Res Bull. 2017;132:1–9. https://doi.org/10.1016/j.brainresbull.2017.05.001.
Li P, Stetler RA, Leak RK, Shi Y, Li Y, Yu W, Bennett MVL, Chen J. Oxidative stress and DNA damage after cerebral ischemia: potential therapeutic targets to repair the genome and improve stroke recovery. Neuropharmacology. 2018;134:208–17. https://doi.org/10.1016/j.neuropharm.2017.11.011.
Lipton P. Ischemic cell death in brain neurons. Physiol Rev. 1999;79:1431–568. https://doi.org/10.1152/physrev.1999.79.4.1431.
Lipton SA. Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults. NeuroRx. 2004;1:101–10. https://doi.org/10.1602/neurorx.1.1.101.
Lipton P. Lysosomal membrane permeabilization as a key player in brain ischemic cell death: a “lysosomocentric” hypothesis for ischemic brain damage. Transl Stroke Res. 2013;4:672–84. https://doi.org/10.1007/s12975-013-0301-2.
Lipton SA, Kim WK, Choi YB, Kumar S, D’Emilia DM, Rayudu PV, Arnelle DR, Stamler JS. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc Natl Acad Sci U S A. 1997;94:5923–8. https://doi.org/10.1073/pnas.94.11.5923.
Liu Y, Wong TP, Aarts M, Rooyakkers A, Liu L, Lai TW, Wu DC, Lu J, Tymianski M, Craig AM, Wang YT. NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo. J Neurosci. 2007;27:2846–57. https://doi.org/10.1523/JNEUROSCI.0116-07.2007.
Liu D-H, Yuan F-G, Hu S-Q, Diao F, Wu Y-P, Zong Y-Y, Song T, Li C, Zhang G-Y. Endogenous nitric oxide induces activation of apoptosis signal-regulating kinase 1 via S-nitrosylation in rat hippocampus during cerebral ischemia-reperfusion. Neuroscience. 2013;229:36–48. https://doi.org/10.1016/j.neuroscience.2012.10.055.
Loh KY, Wang Z, Liao P. Oncotic cell death in stroke. Rev Physiol Biochem Pharmacol. 2019;176:37–64. https://doi.org/10.1007/112_2018_13.
Lu W, Ai H, Peng L, Wang J, Zhang B, Liu X, Luo J. A novel phosphorylation site of N-methyl-D-aspartate receptor GluN2B at S1284 is regulated by Cdk5 in neuronal ischemia. Exp Neurol. 2015;271:251–8. https://doi.org/10.1016/j.expneurol.2015.06.016.
Lucas KK, Dennis EA. Distinguishing phospholipase A2 types in biological samples by employing group-specific assays in the presence of inhibitors. Prostaglandins Other Lipid Mediat. 2005;77:235–48. https://doi.org/10.1016/j.prostaglandins.2005.02.004.
Marinissen MJ, Chiariello M, Tanos T, Bernard O, Narumiya S, Gutkind JS. The small GTP-binding protein RhoA regulates c-jun by a ROCK-JNK signaling axis. Mol Cell. 2004;14:29–41. https://doi.org/10.1016/s1097-2765(04)00153-4.
Marshall J, Dolan BM, Garcia EP, Sathe S, Tang X, Mao Z, Blair LAC. Calcium channel and NMDA receptor activities differentially regulate nuclear C/EBPbeta levels to control neuronal survival. Neuron. 2003;39:625–39. https://doi.org/10.1016/s0896-6273(03)00496-3.
Martin HGS, Wang YT. Blocking the deadly effects of the NMDA receptor in stroke. Cell. 2010;140:174–6. https://doi.org/10.1016/j.cell.2010.01.014.
Matsui T, Amano M, Yamamoto T, Chihara K, Nakafuku M, Ito M, Nakano T, Okawa K, Iwamatsu A, Kaibuchi K. Rho-associated kinase, a novel serine/threonine kinase, as a putative target for small GTP binding protein Rho. EMBO J. 1996;15:2208–16.
Matté C, Mussulini BHM, dos Santos TM, Soares FMS, Simão F, Matté A, de Oliveira DL, Salbego CG, Wofchuk ST, Wyse ATS. Hyperhomocysteinemia reduces glutamate uptake in parietal cortex of rats. Int J Dev Neurosci. 2010;28:183–7. https://doi.org/10.1016/j.ijdevneu.2009.11.004.
Mattson MP, Shea TB. Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci. 2003;26:137–46. https://doi.org/10.1016/S0166-2236(03)00032-8.
Mehta SL, Manhas N, Raghubir R. Molecular targets in cerebral ischemia for developing novel therapeutics. Brain Res Rev. 2007;54:34–66. https://doi.org/10.1016/j.brainresrev.2006.11.003.
Meyer DA, Torres-Altoro MI, Tan Z, Tozzi A, Di Filippo M, DiNapoli V, Plattner F, Kansy JW, Benkovic SA, Huber JD, Miller DB, Greengard P, Calabresi P, Rosen CL, Bibb JA. Ischemic stroke injury is mediated by aberrant Cdk5. J Neurosci. 2014;34:8259–67. https://doi.org/10.1523/JNEUROSCI.4368-13.2014.
Miao W, Qu Z, Shi K, Zhang D, Zong Y, Zhang G, Zhang G, Hu S. RIP3 S-nitrosylation contributes to cerebral ischemic neuronal injury. Brain Res. 2015;1627:165–76. https://doi.org/10.1016/j.brainres.2015.08.020.
Mo S-F, Liao G-Y, Yang J, Wang M-Y, Hu Y, Lian G-N, Kong L-D, Zhao Y. Protection of neuronal cells from excitotoxicity by disrupting nNOS-PSD95 interaction with a small molecule SCR-4026. Brain Res. 2016;1648:250–6. https://doi.org/10.1016/j.brainres.2016.07.012.
Morimoto N, Oida Y, Shimazawa M, Miura M, Kudo T, Imaizumi K, Hara H. Involvement of endoplasmic reticulum stress after middle cerebral artery occlusion in mice. Neuroscience. 2007;147:957–67. https://doi.org/10.1016/j.neuroscience.2007.04.017.
Mouw G, Zechel JL, Gamboa J, Lust WD, Selman WR, Ratcheson RA. Activation of caspase-12, an endoplasmic reticulum resident caspase, after permanent focal ischemia in rat. Neuroreport. 2003;14:183–6. https://doi.org/10.1097/00001756-200302100-00004.
Mrsić-Pelcić J, Zupan G, Maysinger D, Pelcić G, Vitezić D, Simonić A. The influence of MK-801 on the hippocampal free arachidonic acid level and Na+,K+-ATPase activity in global cerebral ischemia-exposed rats. Prog Neuro-Psychopharmacol Biol Psychiatry. 2002;26:1319–26. https://doi.org/10.1016/s0278-5846(02)00296-8.
Muralikrishna Adibhatla R, Hatcher JF. Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia. Free Radic Biol Med. 2006;40:376–87. https://doi.org/10.1016/j.freeradbiomed.2005.08.044.
Mushtaq G, Greig NH, Anwar F, Al-Abbasi FA, Zamzami MA, Al-Talhi HA, Kamal MA. Neuroprotective mechanisms mediated by CDK5 inhibition. Curr Pharm Des. 2016;22:527–34. https://doi.org/10.2174/1381612822666151124235028.
Nada S, Shima T, Yanai H, Husi H, Grant SGN, Okada M, Akiyama T. Identification of PSD-93 as a substrate for the Src family tyrosine kinase Fyn. J Biol Chem. 2003;278:47610–21. https://doi.org/10.1074/jbc.M303873200.
Nair S, Hagberg H, Krishnamurthy R, Thornton C, Mallard C. Death associated protein kinases: molecular structure and brain injury. Int J Mol Sci. 2013;14:13858–72. https://doi.org/10.3390/ijms140713858.
Nakamura T, Tu S, Akhtar MW, Sunico CR, Okamoto S-I, Lipton SA. Aberrant protein s-nitrosylation in neurodegenerative diseases. Neuron. 2013;78:596–614. https://doi.org/10.1016/j.neuron.2013.05.005.
Nakka VP, Gusain A, Raghubir R. Endoplasmic reticulum stress plays critical role in brain damage after cerebral ischemia/reperfusion in rats. Neurotox Res. 2010;17:189–202. https://doi.org/10.1007/s12640-009-9110-5.
Ning K, Pei L, Liao M, Liu B, Zhang Y, Jiang W, Mielke JG, Li L, Chen Y, El-Hayek YH, Fehlings MG, Zhang X, Liu F, Eubanks J, Wan Q. Dual neuroprotective signaling mediated by downregulating two distinct phosphatase activities of PTEN. J Neurosci. 2004;24:4052–60. https://doi.org/10.1523/JNEUROSCI.5449-03.2004.
Obeid R, Herrmann W. Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Lett. 2006;580:2994–3005. https://doi.org/10.1016/j.febslet.2006.04.088.
Oyadomari S, Mori M. Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ. 2004;11:381–9. https://doi.org/10.1038/sj.cdd.4401373.
Parsons MP, Raymond LA. Extrasynaptic NMDA receptor involvement in central nervous system disorders. Neuron. 2014;82:279–93. https://doi.org/10.1016/j.neuron.2014.03.030.
Paschen W, Mengesdorf T. Endoplasmic reticulum stress response and neurodegeneration. Cell Calcium. 2005;38:409–15. https://doi.org/10.1016/j.ceca.2005.06.019.
Pasquale EB. Eph-ephrin bidirectional signaling in physiology and disease. Cell. 2008;133:38–52. https://doi.org/10.1016/j.cell.2008.03.011.
Paul S, Nairn AC, Wang P, Lombroso PJ. NMDA-mediated activation of the tyrosine phosphatase STEP regulates the duration of ERK signaling. Nat Neurosci. 2003;6:34–42. https://doi.org/10.1038/nn989.
Petrovic-Djergovic D, Goonewardena SN, Pinsky DJ. Inflammatory disequilibrium in stroke. Circ Res. 2016;119:142–58. https://doi.org/10.1161/CIRCRESAHA.116.308022.
Pluta R, Ułamek-Kozioł M, Czuczwar SJ. Neuroprotective and neurological/cognitive enhancement effects of curcumin after brain ischemia injury with Alzheimer’s disease phenotype. Int J Mol Sci. 2018;19:4002. https://doi.org/10.3390/ijms19124002.
Poddar R, Paul S. Homocysteine-NMDA receptor-mediated activation of extracellular signal-regulated kinase leads to neuronal cell death. J Neurochem. 2009;110:1095–106. https://doi.org/10.1111/j.1471-4159.2009.06207.x.
Poddar R, Paul S. Novel crosstalk between ERK MAPK and p38 MAPK leads to homocysteine-NMDA receptor-mediated neuronal cell death. J Neurochem. 2013;124:558–70. https://doi.org/10.1111/jnc.12102.
Poddar R, Deb I, Mukherjee S, Paul S. NR2B-NMDA receptor mediated modulation of the tyrosine phosphatase STEP regulates glutamate induced neuronal cell death. J Neurochem. 2010;115:1350–62. https://doi.org/10.1111/j.1471-4159.2010.07035.x.
Poddar R, Chen A, Winter L, Rajagopal S, Paul S. Role of AMPA receptors in homocysteine-NMDA receptor-induced crosstalk between ERK and p38 MAPK. J Neurochem. 2017;142:560–73. https://doi.org/10.1111/jnc.14078.
Prentice H, Modi JP, Wu J-Y. Mechanisms of neuronal protection against excitotoxicity, endoplasmic reticulum stress, and mitochondrial dysfunction in stroke and neurodegenerative diseases. Oxidative Med Cell Longev. 2015;2015:964518. https://doi.org/10.1155/2015/964518.
Rashidian J, Iyirhiaro G, Aleyasin H, Rios M, Vincent I, Callaghan S, Bland RJ, Slack RS, During MJ, Park DS. Multiple cyclin-dependent kinases signals are critical mediators of ischemia/hypoxic neuronal death in vitro and in vivo. Proc Natl Acad Sci U S A. 2005;102:14080–5. https://doi.org/10.1073/pnas.0500099102.
Rivera-Cervantes MC, Torres JS, Feria-Velasco A, Armendariz-Borunda J, Beas-Zárate C. NMDA and AMPA receptor expression and cortical neuronal death are associated with p38 in glutamate-induced excitotoxicity in vivo. J Neurosci Res. 2004;76:678–87. https://doi.org/10.1002/jnr.20103.
Roberg K, Ollinger K. Oxidative stress causes relocation of the lysosomal enzyme cathepsin D with ensuing apoptosis in neonatal rat cardiomyocytes. Am J Pathol. 1998;152:1151–6.
Rodionov RN, Dayoub H, Lynch CM, Wilson KM, Stevens JW, Murry DJ, Kimoto M, Arning E, Bottiglieri T, Cooke JP, Baumbach GL, Faraci FM, Lentz SR. Overexpression of dimethylarginine dimethylaminohydrolase protects against cerebral vascular effects of hyperhomocysteinemia. Circ Res. 2010;106:551–8. https://doi.org/10.1161/CIRCRESAHA.109.200360.
Rostas JA, Brent VA, Voss K, Errington ML, Bliss TV, Gurd JW. Enhanced tyrosine phosphorylation of the 2B subunit of the N-methyl-D-aspartate receptor in long-term potentiation. Proc Natl Acad Sci U S A. 1996;93:10452–6. https://doi.org/10.1073/pnas.93.19.10452.
Rumbaugh G, Vicini S. Distinct synaptic and extrasynaptic NMDA receptors in developing cerebellar granule neurons. J Neurosci. 1999;19:10603–10.
Rungta RL, Choi HB, Tyson JR, Malik A, Dissing-Olesen L, Lin PJC, Cain SM, Cullis PR, Snutch TP, MacVicar BA. The cellular mechanisms of neuronal swelling underlying cytotoxic edema. Cell. 2015;161:610–21. https://doi.org/10.1016/j.cell.2015.03.029.
Sacco RL, Roberts JK, Jacobs BS. Homocysteine as a risk factor for ischemic stroke: an epidemiological story in evolution. Neuroepidemiology. 1998;17:167–73. https://doi.org/10.1159/000026169.
Satoh T, Nakatsuka D, Watanabe Y, Nagata I, Kikuchi H, Namura S. Neuroprotection by MAPK/ERK kinase inhibition with U0126 against oxidative stress in a mouse neuronal cell line and rat primary cultured cortical neurons. Neurosci Lett. 2000;288:163–6. https://doi.org/10.1016/s0304-3940(00)01229-5.
Segura Torres JE, Chaparro-Huerta V, Rivera Cervantres MC, Montes-González R, Flores Soto ME, Beas-Zárate C. Neuronal cell death due to glutamate excitotocity is mediated by p38 activation in the rat cerebral cortex. Neurosci Lett. 2006;403:233–8. https://doi.org/10.1016/j.neulet.2006.04.063.
Semenova MM, Mäki-Hokkonen AMJ, Cao J, Komarovski V, Forsberg KM, Koistinaho M, Coffey ET, Courtney MJ. Rho mediates calcium-dependent activation of p38alpha and subsequent excitotoxic cell death. Nat Neurosci. 2007;10:436–43. https://doi.org/10.1038/nn1869.
Sen U, Munjal C, Qipshidze N, Abe O, Gargoum R, Tyagi SC. Hydrogen sulfide regulates homocysteine-mediated glomerulosclerosis. Am J Nephrol. 2010;31:442–55. https://doi.org/10.1159/000296717.
Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D’Agostino RB, Wilson PWF, Wolf PA. Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. N Engl J Med. 2002;346:476–83. https://doi.org/10.1056/NEJMoa011613.
Shan Y, Liu B, Li L, Chang N, Li L, Wang H, Wang D, Feng H, Cheung C, Liao M, Cui T, Sugita S, Wan Q. Regulation of PINK1 by NR2B-containing NMDA receptors in ischemic neuronal injury. J Neurochem. 2009;111:1149–60. https://doi.org/10.1111/j.1471-4159.2009.06398.x.
Shang Y, Zhang J, Huang EJ. HIPK2-mediated transcriptional control of NMDA receptor subunit expression regulates neuronal survival and cell death. J Neurosci. 2018;38:4006–19. https://doi.org/10.1523/JNEUROSCI.3577-17.2018.
Shen Y, Kishimoto K, Linden DJ, Sapirstein A. Cytosolic phospholipase A(2) alpha mediates electrophysiologic responses of hippocampal pyramidal neurons to neurotoxic NMDA treatment. Proc Natl Acad Sci U S A. 2007;104:6078–83. https://doi.org/10.1073/pnas.0605427104.
Shi J, Wei L. Rho kinase in the regulation of cell death and survival. Arch Immunol Ther Exp. 2007;55:61–75. https://doi.org/10.1007/s00005-007-0009-7.
Shi Z-Q, Sunico CR, McKercher SR, Cui J, Feng G-S, Nakamura T, Lipton SA. S-nitrosylated SHP-2 contributes to NMDA receptor-mediated excitotoxicity in acute ischemic stroke. Proc Natl Acad Sci U S A. 2013;110:3137–42. https://doi.org/10.1073/pnas.1215501110.
Shi Z, Guan Y, Huo YR, Liu S, Zhang M, Lu H, Yue W, Wang J, Ji Y. Elevated total homocysteine levels in acute ischemic stroke are associated with long-term mortality. Stroke. 2015;46:2419–25. https://doi.org/10.1161/STROKEAHA.115.009136.
Shiloh R, Bialik S, Kimchi A. The DAPK family: a structure-function analysis. Apoptosis. 2014;19:286–97. https://doi.org/10.1007/s10495-013-0924-5.
Shu S, Pei L, Lu Y. Promising targets of cell death signaling of NR2B receptor subunit in stroke pathogenesis. Regen Med Res. 2014;2:8. https://doi.org/10.1186/2050-490X-2-8.
Sibarov DA, Abushik PA, Giniatullin R, Antonov SM. GluN2A subunit-containing NMDA receptors are the preferential neuronal targets of homocysteine. Front Cell Neurosci. 2016;10:246. https://doi.org/10.3389/fncel.2016.00246.
Simpkins KL, Guttmann RP, Dong Y, Chen Z, Sokol S, Neumar RW, Lynch DR. Selective activation induced cleavage of the NR2B subunit by calpain. J Neurosci. 2003;23:11322–31.
Sladojevic N, Yu B, Liao JK. ROCK as a therapeutic target for ischemic stroke. Expert Rev Neurother. 2017;17:1167–77. https://doi.org/10.1080/14737175.2017.1395700.
Slevin M, Krupinski J. Cyclin-dependent kinase-5 targeting for ischaemic stroke. Curr Opin Pharmacol. 2009;9:119–24. https://doi.org/10.1016/j.coph.2008.10.003.
Stanika RI, Pivovarova NB, Brantner CA, Watts CA, Winters CA, Andrews SB. Coupling diverse routes of calcium entry to mitochondrial dysfunction and glutamate excitotoxicity. Proc Natl Acad Sci U S A. 2009;106:9854–9. https://doi.org/10.1073/pnas.0903546106.
Steed MM, Tyagi N, Sen U, Schuschke DA, Joshua IG, Tyagi SC. Functional consequences of the collagen/elastin switch in vascular remodeling in hyperhomocysteinemic wild-type, eNOS−/−, and iNOS−/− mice. Am J Physiol Lung Cell Mol Physiol. 2010;299:L301–11. https://doi.org/10.1152/ajplung.00065.2010.
Stegh AH, Schickling O, Ehret A, Scaffidi C, Peterhänsel C, Hofmann TG, Grummt I, Krammer PH, Peter ME. DEDD, a novel death effector domain-containing protein, targeted to the nucleolus. EMBO J. 1998;17:5974–86. https://doi.org/10.1093/emboj/17.20.5974.
Sternberg Z, Schaller B. Central noradrenergic agonists in the treatment of ischemic stroke-an overview. Transl Stroke Res. 2020;11(2):165–84. https://doi.org/10.1007/s12975-019-00718-7.
Stocca G, Vicini S. Increased contribution of NR2A subunit to synaptic NMDA receptors in developing rat cortical neurons. J Physiol. 1998;507(Pt 1):13–24. https://doi.org/10.1111/j.1469-7793.1998.013bu.x.
Su SC, Tsai L-H. Cyclin-dependent kinases in brain development and disease. Annu Rev Cell Dev Biol. 2011;27:465–91. https://doi.org/10.1146/annurev-cellbio-092910-154023.
Sun Y, Chen Y, Zhan L, Zhang L, Hu J, Gao Z. The role of non-receptor protein tyrosine kinases in the excitotoxicity induced by the overactivation of NMDA receptors. Rev Neurosci. 2016;27:283–9. https://doi.org/10.1515/revneuro-2015-0037.
Takasu MA, Dalva MB, Zigmond RE, Greenberg ME. Modulation of NMDA receptor-dependent calcium influx and gene expression through EphB receptors. Science. 2002;295:491–5. https://doi.org/10.1126/science.1065983.
Tian J, Cheng J, Zhang J, Ye L, Zhang F, Dong Q, Wang H, Fu F. Protection of pyruvate against glutamate excitotoxicity is mediated by regulating DAPK1 protein complex. PLoS One. 2014;9:e95777. https://doi.org/10.1371/journal.pone.0095777.
Tovar KR, Westbrook GL. The incorporation of NMDA receptors with a distinct subunit composition at nascent hippocampal synapses in vitro. J Neurosci. 1999;19:4180–8.
Tu W, Xu X, Peng L, Zhong X, Zhang W, Soundarapandian MM, Balel C, Wang M, Jia N, Zhang W, Lew F, Chan SL, Chen Y, Lu Y. DAPK1 interaction with NMDA receptor NR2B subunits mediates brain damage in stroke. Cell. 2010;140:222–34. https://doi.org/10.1016/j.cell.2009.12.055.
Vidaurre OG, Gascón S, Deogracias R, Sobrado M, Cuadrado E, Montaner J, Rodríguez-Peña A, Díaz-Guerra M. Imbalance of neurotrophin receptor isoforms TrkB-FL/TrkB-T1 induces neuronal death in excitotoxicity. Cell Death Dis. 2012;3:e256. https://doi.org/10.1038/cddis.2011.143.
Vieira MM, Schmidt J, Ferreira JS, She K, Oku S, Mele M, Santos AE, Duarte CB, Craig AM, Carvalho AL. Multiple domains in the C-terminus of NMDA receptor GluN2B subunit contribute to neuronal death following in vitro ischemia. Neurobiol Dis. 2016;89:223–34. https://doi.org/10.1016/j.nbd.2015.11.007.
Viviani B, Bartesaghi S, Gardoni F, Vezzani A, Behrens MM, Bartfai T, Binaglia M, Corsini E, Di Luca M, Galli CL, Marinovich M. Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J Neurosci. 2003;23:8692–700.
Vizi ES, Kisfali M, Lőrincz T. Role of nonsynaptic GluN2B-containing NMDA receptors in excitotoxicity: evidence that fluoxetine selectively inhibits these receptors and may have neuroprotective effects. Brain Res Bull. 2013;93:32–8. https://doi.org/10.1016/j.brainresbull.2012.10.005.
Wang YT, Salter MW. Regulation of NMDA receptors by tyrosine kinases and phosphatases. Nature. 1994;369:233–5. https://doi.org/10.1038/369233a0.
Wang J, Liu S, Fu Y, Wang JH, Lu Y. Cdk5 activation induces hippocampal CA1 cell death by directly phosphorylating NMDA receptors. Nat Neurosci. 2003;6:1039–47. https://doi.org/10.1038/nn1119.
Wang X, Han W, Du X, Zhu C, Carlsson Y, Mallard C, Jacotot E, Hagberg H. Neuroprotective effect of Bax-inhibiting peptide on neonatal brain injury. Stroke. 2010;41:2050–5. https://doi.org/10.1161/STROKEAHA.110.589051.
Wang X, Pei L, Yan H, Wang Z, Wei N, Wang S, Yang X, Tian Q, Lu Y. Intervention of death-associated protein kinase 1-p53 interaction exerts the therapeutic effects against stroke. Stroke. 2014;45:3089–91. https://doi.org/10.1161/STROKEAHA.114.006348.
Wang F, Gómez-Sintes R, Boya P. Lysosomal membrane permeabilization and cell death. Traffic. 2018;19:918–31. https://doi.org/10.1111/tra.12613.
Werneburg NW, Guicciardi ME, Bronk SF, Gores GJ. Tumor necrosis factor-alpha-associated lysosomal permeabilization is cathepsin B dependent. Am J Physiol Gastrointest Liver Physiol. 2002;283:G947–56. https://doi.org/10.1152/ajpgi.00151.2002.
Werneburg NW, Guicciardi ME, Bronk SF, Kaufmann SH, Gores GJ. Tumor necrosis factor-related apoptosis-inducing ligand activates a lysosomal pathway of apoptosis that is regulated by Bcl-2 proteins. J Biol Chem. 2007;282:28960–70. https://doi.org/10.1074/jbc.M705671200.
Windelborn JA, Lipton P. Lysosomal release of cathepsins causes ischemic damage in the rat hippocampal slice and depends on NMDA-mediated calcium influx, arachidonic acid metabolism, and free radical production. J Neurochem. 2008;106:56–69. https://doi.org/10.1111/j.1471-4159.2008.05349.x.
Wolter KG, Hsu YT, Smith CL, Nechushtan A, Xi XG, Youle RJ. Movement of Bax from the cytosol to mitochondria during apoptosis. J Cell Biol. 1997;139:1281–92. https://doi.org/10.1083/jcb.139.5.1281.
Writing Group Members, Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Després J-P, Fullerton HJ, Howard VJ, Huffman MD, Isasi CR, Jiménez MC, Judd SE, Kissela BM, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Magid DJ, McGuire DK, Mohler ER, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Rosamond W, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Woo D, Yeh RW, Turner MB, American Heart Association Statistics Committee, Stroke Statistics Subcommittee. Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation. 2016;133:e38–360. https://doi.org/10.1161/CIR.0000000000000350.
Xu J, Zhang Q-G, Li C, Zhang G-Y. Subtoxic N-methyl-D-aspartate delayed neuronal death in ischemic brain injury through TrkB receptor- and calmodulin-mediated PI-3K/Akt pathway activation. Hippocampus. 2007;17:525–37. https://doi.org/10.1002/hipo.20289.
Xu J, Liu Y, Zhang G-Y. Neuroprotection of GluR5-containing kainate receptor activation against ischemic brain injury through decreasing tyrosine phosphorylation of N-methyl-D-aspartate receptors mediated by Src kinase. J Biol Chem. 2008;283:29355–66. https://doi.org/10.1074/jbc.M800393200.
Yamaguchi Y, Pasquale EB. Eph receptors in the adult brain. Curr Opin Neurobiol. 2004;14:288–96. https://doi.org/10.1016/j.conb.2004.04.003.
Yan X-L, Liu D-H, Zhang G-L, Hu S-Q, Chen Y-G, Xu T. S-Nitrosylation of proline-rich tyrosine kinase 2 involves its activation induced by oxygen-glucose deprivation. Neurosci Lett. 2015;597:90–6. https://doi.org/10.1016/j.neulet.2015.04.043.
Yan M, Zhu W, Zheng X, Li Y, Tang L, Lu B, Chen W, Qiu P, Leng T, Lin S, Yan G, Yin W. Effect of glutamate on lysosomal membrane permeabilization in primary cultured cortical neurons. Mol Med Rep. 2016;13:2499–505. https://doi.org/10.3892/mmr.2016.4819.
Yanagisawa D, Kitamura Y, Inden M, Takata K, Taniguchi T, Morikawa S, Morita M, Inubushi T, Tooyama I, Taira T, Iguchi-Ariga SMM, Akaike A, Ariga H. DJ-1 protects against neurodegeneration caused by focal cerebral ischemia and reperfusion in rats. J Cereb Blood Flow Metab. 2008;28:563–78. https://doi.org/10.1038/sj.jcbfm.9600553.
Yang DD, Kuan CY, Whitmarsh AJ, Rincón M, Zheng TS, Davis RJ, Rakic P, Flavell RA. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature. 1997;389:865–70. https://doi.org/10.1038/39899.
Yoneda T, Imaizumi K, Oono K, Yui D, Gomi F, Katayama T, Tohyama M. Activation of caspase-12, an endoplastic reticulum (ER) resident caspase, through tumor necrosis factor receptor-associated factor 2-dependent mechanism in response to the ER stress. J Biol Chem. 2001;276:13935–40. https://doi.org/10.1074/jbc.M010677200.
Yu XM, Askalan R, Keil GJ, Salter MW. NMDA channel regulation by channel-associated protein tyrosine kinase Src. Science. 1997;275:674–8. https://doi.org/10.1126/science.275.5300.674.
Zalckvar E, Berissi H, Eisenstein M, Kimchi A. Phosphorylation of Beclin 1 by DAP-kinase promotes autophagy by weakening its interactions with Bcl-2 and Bcl-XL. Autophagy. 2009a;5:720–2. https://doi.org/10.4161/auto.5.5.8625.
Zalckvar E, Berissi H, Mizrachy L, Idelchuk Y, Koren I, Eisenstein M, Sabanay H, Pinkas-Kramarski R, Kimchi A. DAP-kinase-mediated phosphorylation on the BH3 domain of beclin 1 promotes dissociation of beclin 1 from Bcl-XL and induction of autophagy. EMBO Rep. 2009b;10:285–92. https://doi.org/10.1038/embor.2008.246.
Zhang F, Li C, Wang R, Han D, Zhang Q-G, Zhou C, Yu H-M, Zhang G-Y. Activation of GABA receptors attenuates neuronal apoptosis through inhibiting the tyrosine phosphorylation of NR2A by Src after cerebral ischemia and reperfusion. Neuroscience. 2007;150:938–49. https://doi.org/10.1016/j.neuroscience.2007.09.070.
Zhang M, Li Q, Chen L, Li J, Zhang X, Chen X, Zhang Q, Shao Y, Xu Y. PSD-93 deletion inhibits Fyn-mediated phosphorylation of NR2B and protects against focal cerebral ischemia. Neurobiol Dis. 2014;68:104–11. https://doi.org/10.1016/j.nbd.2014.04.010.
Zhao K, Zhou H, Zhao X, Wolff DW, Tu Y, Liu H, Wei T, Yang F. Phosphatidic acid mediates the targeting of tBid to induce lysosomal membrane permeabilization and apoptosis. J Lipid Res. 2012;53:2102–14. https://doi.org/10.1194/jlr.M027557.
Zhou L, Li F, Xu H-B, Luo C-X, Wu H-Y, Zhu M-M, Lu W, Ji X, Zhou Q-G, Zhu D-Y. Treatment of cerebral ischemia by disrupting ischemia-induced interaction of nNOS with PSD-95. Nat Med. 2010;16:1439–43. https://doi.org/10.1038/nm.2245.
Zhou Z, Liang Y, Qu H, Zhao M, Guo F, Zhao C, Teng W. Plasma homocysteine concentrations and risk of intracerebral hemorrhage: a systematic review and meta-analysis. Sci Rep. 2018;8:2568. https://doi.org/10.1038/s41598-018-21019-3.
Zhou Y-F, Wang J, Deng M-F, Chi B, Wei N, Chen J-G, Liu D, Yin X, Lu Y, Zhu L-Q. The peptide-directed lysosomal degradation of CDK5 exerts therapeutic effects against stroke. Aging Dis. 2019;10:1140–5. https://doi.org/10.14336/AD.2018.1225.
Zhu Y, Pak D, Qin Y, McCormack SG, Kim MJ, Baumgart JP, Velamoor V, Auberson YP, Osten P, van Aelst L, Sheng M, Zhu JJ. Rap2-JNK removes synaptic AMPA receptors during depotentiation. Neuron. 2005;46:905–16. https://doi.org/10.1016/j.neuron.2005.04.037.
Zhu J, Xu S, Li S, Yang X, Yu X, Zhang X. Up-regulation of GluN2A-containing NMDA receptor protects cultured cortical neuron cells from oxidative stress. Heliyon. 2018;4:e00976. https://doi.org/10.1016/j.heliyon.2018.e00976.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Engin, A., Engin, A.B. (2021). N-Methyl-D-Aspartate Receptor Signaling-Protein Kinases Crosstalk in Cerebral Ischemia. In: Engin, A.B., Engin, A. (eds) Protein Kinase-mediated Decisions Between Life and Death. Advances in Experimental Medicine and Biology, vol 1275. Springer, Cham. https://doi.org/10.1007/978-3-030-49844-3_10
Download citation
DOI: https://doi.org/10.1007/978-3-030-49844-3_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-49843-6
Online ISBN: 978-3-030-49844-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)